DE602005012317D1 - Verwendung von acetyl-l-carinitin zur behandlung des fibromyalgischen syndroms - Google Patents

Verwendung von acetyl-l-carinitin zur behandlung des fibromyalgischen syndroms

Info

Publication number
DE602005012317D1
DE602005012317D1 DE602005012317T DE602005012317T DE602005012317D1 DE 602005012317 D1 DE602005012317 D1 DE 602005012317D1 DE 602005012317 T DE602005012317 T DE 602005012317T DE 602005012317 T DE602005012317 T DE 602005012317T DE 602005012317 D1 DE602005012317 D1 DE 602005012317D1
Authority
DE
Germany
Prior art keywords
acetyl
treatment
syndrome
fibromyalgian
carinitine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE602005012317T
Other languages
German (de)
English (en)
Inventor
Aleardo Koverech
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sigma Tau Industrie Farmaceutiche Riunite SpA
Original Assignee
Sigma Tau Industrie Farmaceutiche Riunite SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Industrie Farmaceutiche Riunite SpA filed Critical Sigma Tau Industrie Farmaceutiche Riunite SpA
Publication of DE602005012317D1 publication Critical patent/DE602005012317D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
DE602005012317T 2004-12-13 2005-11-10 Verwendung von acetyl-l-carinitin zur behandlung des fibromyalgischen syndroms Expired - Lifetime DE602005012317D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT000606A ITRM20040606A1 (it) 2004-12-13 2004-12-13 Uso della acetil l-carnitina per il trattamento della sindrome fibromialgica.
PCT/EP2005/012054 WO2006063639A1 (en) 2004-12-13 2005-11-10 Use of acetyl l-carnitine for the treatment of fibromyalgic syndrome

Publications (1)

Publication Number Publication Date
DE602005012317D1 true DE602005012317D1 (de) 2009-02-26

Family

ID=35708966

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005012317T Expired - Lifetime DE602005012317D1 (de) 2004-12-13 2005-11-10 Verwendung von acetyl-l-carinitin zur behandlung des fibromyalgischen syndroms

Country Status (16)

Country Link
US (1) US8013016B2 (https=)
EP (1) EP1824472B1 (https=)
JP (1) JP5057990B2 (https=)
KR (1) KR101240182B1 (https=)
AT (1) ATE419847T1 (https=)
CA (1) CA2585560C (https=)
CY (1) CY1110576T1 (https=)
DE (1) DE602005012317D1 (https=)
DK (1) DK1824472T3 (https=)
ES (1) ES2320788T3 (https=)
IT (1) ITRM20040606A1 (https=)
MX (1) MX2007006954A (https=)
PL (1) PL1824472T3 (https=)
PT (1) PT1824472E (https=)
SI (1) SI1824472T1 (https=)
WO (1) WO2006063639A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3248653A1 (en) * 2011-06-24 2017-11-29 K-Pax Pharmaceuticals, Inc. Compositions for the treatment of chronic fatigue
ES2962933T3 (es) 2020-12-14 2024-03-21 Ims Gear Se & Co Kgaa Procedimiento para la corrección de una señal de medición dependiente del tiempo de una unidad de motor-engranaje, así como procedimiento para detectar desgaste y/o un deterioro de la misma mediante este procedimiento de corrección

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1150396B (it) * 1982-12-09 1986-12-10 Sigma Tau Ind Farmaceuti Impiego di alcanoil l-carnitine per il trattamento terapeutico di miopa tie e distrofie muscolari
EP0681839A3 (en) * 1994-05-12 1997-11-12 Hirohiko Kuratsune A pharmaceutical preparation comprising an acylcarnitine
US6025368A (en) * 1997-02-25 2000-02-15 Celtrix Pharmaceuticals, Inc. Method for treating the symptoms of chronic stress-related disorders using IGF
US5935949A (en) * 1998-03-20 1999-08-10 Trustees Of Dartmouth College Use of androgen therapy in fibromyalgia and chronic fatigue syndrome
US6803387B1 (en) * 1999-03-19 2004-10-12 Abbott Gmbh & Co. Kg Treatment of neuropathic pain or fibromyalgia
ITRM20010293A1 (it) * 2001-05-29 2002-11-29 Sigma Tau Ind Farmaceuti Uso della acetil-l-carnetina per la preparazione di un medicamento per la prevenzione del dolore.
BR0309875A (pt) * 2002-05-03 2007-04-10 Israel Inst For Biolog Res Isr métodos e composições para tratamento de distúrbios do sistema nervoso periférico e novos compostos úteis para isto

Also Published As

Publication number Publication date
KR20070091317A (ko) 2007-09-10
US8013016B2 (en) 2011-09-06
JP5057990B2 (ja) 2012-10-24
CA2585560A1 (en) 2006-06-22
ATE419847T1 (de) 2009-01-15
EP1824472B1 (en) 2009-01-07
CY1110576T1 (el) 2015-04-29
ES2320788T3 (es) 2009-05-28
EP1824472A1 (en) 2007-08-29
PT1824472E (pt) 2009-03-31
SI1824472T1 (sl) 2009-04-30
PL1824472T3 (pl) 2009-05-29
KR101240182B1 (ko) 2013-03-07
JP2008534433A (ja) 2008-08-28
ITRM20040606A1 (it) 2005-03-13
MX2007006954A (es) 2007-08-02
CA2585560C (en) 2013-01-08
WO2006063639A1 (en) 2006-06-22
DK1824472T3 (da) 2009-03-30
US20090076146A1 (en) 2009-03-19

Similar Documents

Publication Publication Date Title
DE60109044D1 (de) Arzneimittel zur behandlung der mucositis, stomatitis und des behcetschen syndroms
ATE390407T1 (de) Phenethanolamin-derivate zur behandlung von atemwegserkrankungen
DE502007002101D1 (de) Arzneimittel mit Dobesilat-Calcium zur Behandlung und Prophylaxe von Sehnenerkrankungen
IL183401A (en) Use of ornithine and ornithine with at least one of phenylacetate and phenylbutyrate in the manufacture of products and compositions containing them for use in preventing or treating liver decompensation or hepatic encephalopathy
NO20076405L (no) Anvendelse av 24-nor-UDCA
DE59914712D1 (de) Verwendung von inhibitoren des kqt1-kanals zur herstellung eines medikaments zur behandlung von krankheiten, die durch helminthen und ektoparasiten hervorgerufen werden
CY1109051T1 (el) Χρηση καρνιτινων για την προληψη και/ή θεραπεια διαταραχων που προκαλουνται απο την ανδροπαυση
UA81573C2 (en) Use of agomelatine for the preparation of medicaments for the treatment of sleep disorders in depressed patients
ATE311866T1 (de) Verwendung von r-arylpropionsäuren zur herstellung von arzneimitteln zur behandlung von erkrankungen rheumatischer natur
DE60026491D1 (de) Melagatran zur behandlung von entzündungen
DE602005012317D1 (de) Verwendung von acetyl-l-carinitin zur behandlung des fibromyalgischen syndroms
DE60200160D1 (de) Verwendung von Cilobradine oder pharmazeutisch akzeptablen Salze zur Behandlung oder Prävention von Herzversagen
DE60319241D1 (de) Analoga zur behandlung von thalassämie
ATE281172T1 (de) Verwendung von cdp-choline zur behandlung des alkoholentzugsyndroms
CY1107037T1 (el) Χρηση ακετυλ l-καρνιτινης για την παρασκευη ενος φαρμακου για την προληπτικη αγωγη του μετεγχειρητικου πονου
PL372924A1 (en) Combined use of l-carnitine, acetyl l-carnitine and propionyl l-carnitine for the treatment of oligoasthenoteratospermia
CY1112144T1 (el) Ενωση χρησιμη για την προληψη και θεραπεια της υπερτροφιας αριστερης κοιλιας σε ασθενεις υπο αιμοκαθαρση
DE60305018D1 (de) Citalopram zur behandlung von bluthochdruck
DE60206391D1 (de) Verwendung von thiazolderivaten zur herstellung eines medikaments zur behandlung von chronischen obstruktiven atemwegserkrankungen
ATE330597T1 (de) Verwendung von fibrate zur herstellung eines arzneimittel zur behandlung von kongestiven herzversagens
ATE365038T1 (de) ARZNEIMITTEL ZUR BEHANDLUNG DES ßSYSTEMIC INFLAMMATORY RESPONSE SYNDROMEß
DK1399143T3 (da) Anvendelsen af Acetyl L-carnitin til fremstilling af et lægemiddel til behandling af anhedoni
ATE353638T1 (de) Verwendung von nf-kappa b hemmern zur behandlung von brustdrüsenentzündung
ATE418977T1 (de) Verwendung von phenylacetylderivaten zur herstellung eines arzneimittels zur behandlung der von-hippel-lindau-erkrankung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition